Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma

被引：0
|
作者：
Kao, H-F. [1 ]
Hong, R-L. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1062P
引用
收藏
页码：379 / 379
页数：1
相关论文
共 50 条
  • [1] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, Hsiang-Fong
    Huang, Huai-Cheng
    Liao, Bin-Chi
    Hong, Ruey-Long
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [2] Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
    Chen, Wen-Chun
    Chu, Pen-Yuan
    Lee, Yu-Ting
    Lu, Wen-Bin
    Liu, Chun-Yu
    Chang, Peter Mu-Hsin
    Yang, Muh-Hwa
    MEDICINE, 2017, 96 (52)
  • [3] Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis
    Kao, Hsiang-Fong
    Liao, Bin-Chi
    Huang, Yen-Lin
    Huang, Huai-Cheng
    Chen, Chun-Nan
    Chen, Tseng-Cheng
    Hong, Yuan-Jing
    Chan, Ching-Yi
    Chia, Jean-San
    Hong, Ruey-Long
    CLINICAL CANCER RESEARCH, 2022, 28 (08) : 1560 - 1571
  • [4] Pembrolizumab for cisplatin-failure recurrent/metastatic head and neck squamous cell carcinoma
    Chen, W-C.
    Chang, P. M-H.
    Lee, Y-T.
    Lu, W-B.
    Yang, M-H.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Afatinib and pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma (ALPHA Study): A phase II study with biomarker analysis.
    Kao, Hsiang-fong
    Liao, Bin-Chi
    Huang, Yen-Lin
    Huang, Huai-Cheng
    Chen, Chun-Nan
    Chen, Tseng-Cheng
    Hong, Yuan-Jing
    Chan, Ching-Yi
    Hong, Ruey-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
    Saba, Nabil F.
    Steuer, Conor E.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Magliocca, Kelly
    Patel, Mihir
    Schmitt, Nicole C.
    Stokes, William
    Bates, James E.
    Rudra, Soumon
    Remick, Jill
    McDonald, Mark
    Abousaud, Marin
    Tan, Aik Choon
    Fadlullah, Muhammad Zaki Hidayatullah
    Chaudhary, Ritu
    Muzaffar, Jameel
    Kirtane, Kedar
    Liu, Yuan
    Chen, Georgia Z.
    Shin, Dong M.
    Teng, Yong
    Chung, Christine H.
    NATURE MEDICINE, 2023, 29 (04) : 880 - 887
  • [7] Role of Hematological Markers in Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma Treated With Pembrolizumab
    Hagiwara, Kohei
    Matsuki, Takashi
    Okada, Takuro
    Fushimi, Chihiro
    Kondo, Takahito
    Takahashi, Hideaki
    Okamoto, Isaku
    Tokashiki, Kunihiko
    Hanyu, Kenji
    Kishida, Takuma
    Ito, Tatsuya
    Yamashita, Gai
    Tsukahara, Kiyoaki
    Masubuchi, Tatsuo
    Tada, Yuichiro
    Momiyama, Kaho
    Yaguchi, Ryohei
    Oridate, Nobuhiko
    Omura, Go
    Yamashita, Taku
    ANTICANCER RESEARCH, 2024, 44 (09) : 4057 - 4072
  • [8] Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective Study
    Okada, Takuro
    Fushimi, Chihiro
    Matsuki, Takashi
    Tokashiki, Kunihiko
    Takahashi, Hideaki
    Okamoto, Isaku
    Sato, Hiroki
    Kondo, Takahito
    Hanyu, Kenji
    Kishida, Takuma
    Ito, Tatsuya
    Yamashita, Gai
    Masubuchi, Tatsuo
    Tada, Yuichiro
    Miura, Koki
    Omura, Go
    Yamashita, Taku
    Oridate, Nobuhiko
    Tsukahara, Kiyoaki
    ANTICANCER RESEARCH, 2023, 43 (06) : 2717 - 2724
  • [9] Afatinib in squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
  • [10] Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040
    Harrington, Kevin J.
    Soulieres, Denis
    Le Tourneau, Christophe
    Dinis, Jose
    Licitra, Lisa F.
    Ahn, Myung-Ju
    Soria, Ainara
    Machiels, Jean-Pascal H.
    Mach, Nicolas
    Mehra, Ranee
    Burtness, Barbara
    Ellison, Misoo C.
    Cheng, Jonathan D.
    Chirovsky, Diana Romana
    Swaby, Ramona F.
    Cohen, Ezra E. W.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (02): : 171 - 181
12345